Showing results (1461-1470 of 1,970) with videos related to

Sort By:
Pageof 197
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|December 18, 2022
What explains very poor Yelp reviews of oral and maxillofacial surgeons in private practice?Dani Stanbouly, Michael Baron, Ralph Pierre, et al.
Proceedings of the American Thoracic Society|March 3, 2011
An official ATS/AASM/ACCP/ERS workshop report: Research priorities in ambulatory management of adults with obstructive sleep apneaSamuel T Kuna, M Safwan Badr, R John Kimoff, et al.
Circulation|November 24, 1999
Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donorsJ M Chen, S Cullinane, T B Spanier, et al.
Frontiers in Physiology|November 4, 2021
Effect of Maternal Obstructive Sleep Apnea-Hypopnea on 24-Hour Blood Pressure, Nocturnal Blood Pressure Dipping and Arterial Stiffness in Hypertensive Disorders of PregnancyPattaraporn Panyarath, Noa Goldscher, Sushmita Pamidi, et al.
Nature Genetics|August 11, 1998
Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresiaR J Clifton-Bligh, J M Wentworth, P Heinz, et al.
The Journal of Otolaryngology|September 27, 2005
High prevalence of obstructive sleep apnea among patients with head and neck cancerRichard J Payne, Michael P Hier, Karen M Kost, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 12, 2004
Physiological significance of troponin T binding domains in striated muscle tropomyosinGanapathy Jagatheesan, Sudarsan Rajan, Natalia Petrashevskaya, et al.
Reproductive Biomedicine Online|August 17, 2013
The impact of sperm DNA damage in assisted conception and beyond: recent advances in diagnosis and treatmentSheena E M Lewis, R John Aitken, Sarah J Conner, et al.
Bioanalysis|November 24, 2012
Conference report: emerging technology for bioanalysis in the next decadeJames E Demuth, Qin C Ji, Brian P Booth, et al.
European Journal of Cancer (Oxford, England : 1990)|November 13, 2013
The cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: results from the Australasian phase III MAX studyHannah E Carter, Diana Zannino, R John Simes, et al.
Pageof 197